A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients for whom other treatments had failed and raising hopes for a safer, more ...

Introduction: Ulcerative colitis is an inflammatory bowel disease that is limited to the colon. First-line treatment consists of rectally administered suppositories, foam or enema. Adherence to rectal ...

For decades, scientists have puzzled over why smoking makes Crohn’s disease worse but seems to protect people from ulcerative colitis. Now, researchers at RIKEN have discovered that smoking creates ...

ABSTRACT: Background: The treatment of ulcerative colitis (UC) has evolved significantly with the introduction of biotherapies and advanced endoscopic techniques, reducing the need for surgical ...

ABSTRACT: Background: The treatment of ulcerative colitis (UC) has evolved significantly with the introduction of biotherapies and advanced endoscopic techniques, reducing the need for surgical ...

What was the aim of this review? We aimed to find out whether tacrolimus is an effective and safe treatment in people with ulcerative colitis that are difficult to treat in any other way. Ulcerative ...

Rectally administered topical agents have demonstrated efficacy in the maintenance of distal colitis (DC) and proctitis and as they are rarely associated with significant blood drug levels, side ...

Whether it's a dull ache, sharp cramp or persistent discomfort, most of us have experienced some degree of stomach pain throughout our lives. While something as mild as indigestion, gas, bloating or ...

Metabolomics and machine learning identified serum biomarkers that predict ulcerative colitis extent, offering insight beyond disease activity levels. By combining metabolomics and machine learning, ...

Colitis and ulcerative colitis (UC) can look very similar because they share symptoms like abdominal pain, diarrhea, and bloody stool, and they both involve inflammation of the colon (the large ...

Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S.

Ulcerative colitis (UC), a type of inflammatory bowel disease (IBD) in which the lining of the colon becomes inflamed, causes symptoms that include urgent bowel movements, bloody stools, and cramping.